HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 34 filers reported holding HARPOON THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4,065 | +46.7% | 5,725 | +53.7% | 0.00% | – |
| Q1 2023 | $2,771 | +29.9% | 3,724 | +26.7% | 0.00% | – |
| Q4 2022 | $2,134 | -84.8% | 2,940 | -78.9% | 0.00% | – |
| Q3 2022 | $14,000 | -76.7% | 13,957 | -56.1% | 0.00% | – |
| Q2 2022 | $60,000 | -36.2% | 31,827 | +67.9% | 0.00% | – |
| Q1 2022 | $94,000 | -3.1% | 18,953 | +47.8% | 0.00% | – |
| Q4 2021 | $97,000 | -83.4% | 12,825 | -82.6% | 0.00% | – |
| Q3 2021 | $583,000 | -80.3% | 73,762 | -65.4% | 0.00% | – |
| Q2 2021 | $2,955,000 | +8591.2% | 212,991 | +12816.4% | 0.00% | – |
| Q1 2021 | $34,000 | -85.5% | 1,649 | -88.3% | 0.00% | – |
| Q4 2020 | $234,000 | +431.8% | 14,114 | +442.6% | 0.00% | – |
| Q3 2020 | $44,000 | -86.4% | 2,601 | -86.6% | 0.00% | – |
| Q2 2020 | $323,000 | +107.1% | 19,437 | +44.5% | 0.00% | – |
| Q1 2020 | $156,000 | -48.5% | 13,447 | -34.2% | 0.00% | – |
| Q4 2019 | $303,000 | +252.3% | 20,450 | +223.3% | 0.00% | – |
| Q3 2019 | $86,000 | +760.0% | 6,326 | +678.1% | 0.00% | – |
| Q2 2019 | $10,000 | +100.0% | 813 | +50.3% | 0.00% | – |
| Q1 2019 | $5,000 | – | 541 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 3,156,699 | $15,689,000 | 7.73% |
| MPM ASSET MANAGEMENT LLC | 3,131,388 | $15,563,000 | 5.32% |
| MPM BioImpact LLC | 3,196,707 | $15,888,000 | 4.26% |
| ACUTA CAPITAL PARTNERS, LLC | 497,500 | $2,473,000 | 1.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 151,445 | $2,771,000 | 0.62% |
| Orbimed Advisors | 3,039,508 | $15,106,000 | 0.24% |
| Artal Group S.A. | 1,000,000 | $4,970,000 | 0.21% |
| Cormorant Asset Management, LP | 540,600 | $2,687,000 | 0.21% |
| DAFNA Capital Management LLC | 105,163 | $523,000 | 0.14% |
| Ikarian Capital, LLC | 117,009 | $582,000 | 0.08% |